Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > So, why are we bid down almost 8%?

<< Previous

Bullboard Posts

Next >>

Comment by qwerty22on Jul 06, 2021 12:17pm

111 Views

Post# 33499180

RE:RE:RE:RE:RE:So, why are we bid down almost 8%?

"Shouldn't take this long"

Everything in biotech takes this long (and longer).

Steel yourself for a quiet summer. If something happens it'll be a happy surprise.

Bucknelly21 wrote: Kinda feels like to me they have wino mostly hot air on their call, where's the new engagement with investors, more conferences ect. Shouldn't take this long. They have plenty of information to share

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks